Not Signed In - Northwestern Researchers Launch Avastin Trial For Pancreatic Tumors
Wed, 22 Feb 2006 03:00 AM EST
... A Phase II clinical trial is under way at Northwestern Memorial Hospital to determine if bevacizumab (also referred to as Avastin®, an anti-angiogenesis drug that is designed to inhibit the growth of blood vessels in tumors) in combination with abdominal radiation therapy and chemotherapy can reduce localized pancreatic tumors that have not metastasized or spread to other systems or organs in the body. ...
Related Topics
- Bevacizumab Injection
- Clinical Trials
- Pancreatic Cancer
- Tarceva
- Pancreatic Insufficiency
- Benign Tumors
- Pancreatic Diseases
- Benign Tumor
- Cetuximab
- Brain and Spinal Tumors
- Ewing's Family of Tumors
- Pancreatic Disease
- Sarcoma, Ewing's Family of Tumors
- Pancreatic Cancer, Childhood
- Ovarian Low Malignant Potential Tumors
- Childhood Extracranial Germ Cell Tumors
- Supratentorial Primitive Neuroectodermal Tumors, Childhood
- Pancreatic Cancer, Islet Cell
- Islet Cell Carcinoma (Pancreatic)
- Childhood Supratentorial Primitive Neuroectodermal Tumors and Pineoblastoma
email this page
print this page
bookmark this page
feedback on this page
